0
CytRX Corporation Banner Image

CytRX Corporation

  • Ticker CYTR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CytRX Corporation Logo Image
  • 1-10 Employees
  • Based in Los Angeles, California
CytRx Corporation, a biopharmaceutical research and development company, specializes in oncology. Its drug development pipeline includes INNO-206, which is in Phase Ib clinical trial and is completing Phase Ib/II clinical trial for the treatment for soft tissue sarcomas; and tamibarotene that in Phase IIb clinical trial for the treatment of non-small-cell lung cancer and is in a clinicalMore trial as a treatment for acute promyelocytic leukemia.
CytRX Corporation

Most Recent Annual Report

CytRX Corporation MOST RECENT 2020 Annual Report

CytRX Corporation does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports